Cargando…
Synergistic Antitumor Effect of Dichloroacetate in Combination with 5-Fluorouracil in Colorectal Cancer
Dichloroacetate (DCA), an inhibitor of pyruvate dehydrogenase kinase (PDK), has been recently demonstrated as a promising nontoxic antineoplastic agent that promotes apoptosis of cancer cells. In the present study, we aimed to investigate the antitumor effect of DCA combined with 5-Fluorouracil (5-F...
Autores principales: | Tong, Jingtao, Xie, Ganfeng, He, Jinxia, Li, Jianjun, Pan, Feng, Liang, Houjie |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3043319/ https://www.ncbi.nlm.nih.gov/pubmed/21403907 http://dx.doi.org/10.1155/2011/740564 |
Ejemplares similares
-
Synergistic antitumor effect of puerarin combined with 5-fluorouracil on gastric carcinoma
por: GUO, XU-FENG, et al.
Publicado: (2015) -
The Synergistic Antitumor Effect of 5-Fluorouracil Combined with Allicin against Lung and Colorectal Carcinoma Cells
por: Țigu, Adrian Bogdan, et al.
Publicado: (2020) -
ABHD5 blunts the sensitivity of colorectal cancer to fluorouracil via promoting autophagic uracil yield
por: Ou, Juanjuan, et al.
Publicado: (2019) -
Functional Analysis of SNPs in the ERCC5 Promoter in Advanced Colorectal Cancer Patients Treated With Oxaliplatin-Based Chemotherapy
por: Chen, Jianfang, et al.
Publicado: (2016) -
Synergistic antitumor effect of 5-fluorouracil with the novel LSD1
inhibitor ZY0511 in colorectal cancer
por: Peng, Wen, et al.
Publicado: (2020)